$2.29 +0.04 (1.78%)
Avalon GloboCare Corp. Common Stock (ALBT)
Avalon GloboCare Corp. is a biotechnology company focused on developing and commercializing cell-based therapies and diagnostic products. The company explores innovative solutions in regenerative medicine, immunotherapy, and personalized healthcare, aiming to advance treatment options in various medical fields.
Company News
Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom
Avalon GloboCare is launching its KetoAir breathalyzer device in the United Kingdom on September 1, 2025, targeting individuals pursuing ketogenic diets for health and wellness purposes.
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - ALBT, NDOI, DNB, RSLS
The M&A Class Action Firm is investigating the proposed mergers of Avalon GloboCare, Endo, Dun & Bradstreet, and ReShape Lifesciences, providing details on the terms of each deal.